Tositumomab and iodine I 131 tositumomab (BEXXAR (R) therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-hodgkin's lymphoma (NHL Meeting Abstract


Authors: Knox, S. K.; Meredith, R. F.; Coleman, M.; Kaminski, M. S.; Zelenetz, A. D.; Vose, J. M.
Abstract Title: Tositumomab and iodine I 131 tositumomab (BEXXAR (R) therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-hodgkin's lymphoma (NHL
Meeting Title: 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 60
Issue: 1 Suppl.
Meeting Dates: 2004 Oct 3-7
Meeting Location: Atlanta, GA
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2004-09-01
Start Page: S220
Language: English
ACCESSION: WOS:000223854700149
PROVIDER: wos
PUBMED: 15358435
DOI: 10.1016/j.ijrobp.2004.06.174
Notes: Meeting Abstract: 149 -- 46th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology -- OCT 03-07, 2004 -- Atlanta, GA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    785 Zelenetz